BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:[ U.S. DEPARTMENT OF DEFENSE - RESTORE Research Award | Research f
 unding ]
DTSTART;VALUE=DATE:20190903
DTSTAMP:20260916T194619Z
UID:d3f50b6c16a64e57c236b9e7b9ead4401cf9d495490603f40067b7b5
CATEGORIES:Call for proposal
DESCRIPTION:Aim: Through the Congressionally Directed Medical Research Pro
 gram (CDMRP)\, the Department of Defense is announcing the Restoring Warfi
 ghters with Neuromusculoskeletal Injuries Research Award (RESTORE). The in
 tent of the RESTORE mechanism is to provide support for research of except
 ional scientific merit that proposes solutions for optimal management\, tr
 eatment\, and restoration following Service-related neuromusculoskeletal i
 njury. Research will accelerate progress toward returning Warfighters to c
 ombat readiness following neuromusculoskeletal injury and will ultimately 
 benefit all patients with such injuries.\n \nRESTORE is structured with t
 hree different Research Levels:\n\n	Research Level 1—New ideas that repr
 esent innovative approaches and have the potential to make an important co
 ntribution within the RESTORE Focus Areas (see below)\n	Research Level 2
 —Advancement of laboratory discovery\, population-based studies\, or cli
 nical knowledge into clinical application and acceleration toward a clinic
 al solution\n	Research Level 3—Clinical trials with the potential to hav
 e a significant impact on Warfighters who have incurred neuromusculoskelet
 al injuries\n\n \nTo meet the intent of the award mechanism\, application
 s RESTORE must address research in program’s Focus Areas\, which are lis
 ted at the end of this announcement.\n \nFunding:        Research l
 evel 1: Maximum USD $ 500’000\n                    
     Research level 2: Maximum USD $ 1’500’000\n          
               Research level 3: Maximum USD $ 3’000’000\n
  \nDuration:      Research level 1: 3 years\n            
             Research level 2: 4 years\n            
             Research level 3: 4 years\n \nEligibility: Applica
 nts from international organizations or institutions are eligible to apply
 \, and there are no citizenship restrictions. Investigators at or above th
 e level of Assistant Professor (or equivalent) may be named by the organiz
 ation as the PI on the application.\n \nHow to Apply: Pre-applications ar
 e submitted through the eBRAP platform. They should contain contact inform
 ation\, a list of collaborators and key personnel\, preproposal narrative\
 , and supporting documents as suggested on the platform. Full applications
  (by invitation) will be made via a Grants.gov workspace. Full application
  packages can be downloaded from Grants.gov at any time.\n \nPre-Applicat
 ion Deadline: 03 September 2019\, 5:00 p.m. EST (23:00 CET)\nFull Applicat
 ion Deadline:  16 December 2019\, 11:59 p.m. EST (05:59 17 Dec\, CET)\n 
 \nGrants.gov Funding Opportunity Number: 81XWH-19-DMRDP-CRMRP-RESTORE\n \
 nFurther information\n\n\n	To see the program announcement\, navigate to t
 he search page on Grants.gov and search for the Opportunity Number 81XWH-1
 9-DMRDP-CRMRP-RESTORE.\n	For questions about the eBRAP or Grants.gov platf
 orms\, contact the Research Office.\n\n \nRESTORE Focus Areas\n \n\n	Sol
 utions that accurately diagnose neuromusculoskeletal injuries in training 
 and operational environments to optimize management and treatment decision
 s\n	Solutions to accelerate recovery and restore Warfighter performance in
  training and operational environments\n	Objective support tools to enable
  providers to assess function and performance throughout treatment and pre
 dict long-term outcomes\n	Pain management strategies following acute and/o
 r chronic neuromusculoskeletal injury that are fast-acting\, long-lasting\
 , and free of adverse side effects\n	Optimization of Warfighter performanc
 e following limb trauma or loss. Examples include\, but are not limited to
 \, prosthetics and orthotic solutions (e.g.\, intuitive control and sensat
 ion\, interface\, interoperability\, prescription\, and training)\, as wel
 l as regenerative rehabilitation solutions addressing peripheral nerves\, 
 skeletal muscle\, and/or bone. Technology development is allowed. Regenera
 tive studies without a rehabilitative component are not responsive to this
  funding opportunity\n
LOCATION:
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR